# FDA recall D-0098-2023

> **RemedyRepack Inc.** · Class II · drug recall initiated 2022-12-20.

## Product

Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.

## Reason for recall

Failed Impurities/Degradation specifications

## Distribution

Product was distributed to one account in PA.

## Key facts

- **Recall number:** D-0098-2023
- **Recalling firm:** RemedyRepack Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-20
- **Report date:** 2023-01-18
- **Termination date:** 2023-03-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indiana, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0098-2023

## Citation

> AI Analytics. FDA recall D-0098-2023. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-0098-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*